ONE Bio Obtains High-Tech Enterprise Certification
19 January 2011 - 8:30AM
Marketwired
ONE Bio, Corp. ("ONE" or the "Company")
(OTCBB: ONBI), an innovative company utilizing green process
manufacturing to produce raw chemicals and herbal extracts, natural
and health supplements and organic products, announced that its
subsidiary, Green Planet Bioengineering, Co., Ltd. through its
Chinese operating unit, was granted the designation of high-tech
enterprise by the Fujian provincial High-tech Department (Document
No.: Fujian High-tech).
High-tech enterprise designation is achieved by a state
supported China resident enterprise (excluding those in Hong Kong,
Macao and Taiwan areas) that among other requirements has developed
research work, converted the research to production and the
developed IP technology forms part of the company's operations and
competitive edge.
The honor received by the Company is a statement that it has
achieved national level recognition as a high-tech enterprise
providing it the ability to receive a 10% tax relief benefit
starting in the 2nd quarter of this year. In addition, the Company
will benefits from additional tax subsidies related to the
production and sell of medicinal plants and agricultural products
like sarcandra glabra, polygonum cuspidatum, reishi mushroom and
others which are some of the Company's highly sought-after
products. The high-tech designation good for 3 years once obtained
will reduce the tax rate of the Company starting in the 2nd quarter
which will increase the Company's net income for every dollar of
pre-tax profit earned by the Company.
"Obtaining the high-tech designation in China is a great
achievement for our Company both in terms of customer and general
market recognition as well as for financial benefits," stated ONE's
CEO Marius Silvasan. "We drive innovation through our in-house
R&D team. Our team's research has allowed us to file patents
related to various extraction processes that we utilize today
throughout our operations. This IP technology has allowed us to be
at the forefront of our industry and yield a high gross profit
margin on the sale of our raw extracts," added Silvasan.
About ONE Bio, Corp.
ONE Bio, Corp. ("ONE") (OTCBB: ONBI) (www.onehcorp.com)
headquartered in Miami, FL, is an innovative company utilizing
patented green process manufacturing to produce raw chemicals and
herbal extracts, natural supplements and organic products. ONE is
focused on the Asia Pacific region. Key products include widely
recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic
fertilizers, and organic bamboo health food and beverages. ONE has
experienced solid organic growth driven by a robust demand for its
products in China, Japan and the United States.
This press release includes statements that constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE
Bio, Corp. claims the protection of the safe-harbor for
forward-looking statements contained in the Reform Act. These
forward-looking statements are often characterized by the terms
"may," "believes," "projects," "expects," or "anticipates," and do
not reflect historical facts. Specific forward-looking statements
contained in this press release include, but are not limited to:
our successful integration of diversified growth companies, impact
of the company's expansion plan, and new business development
success, future financial results, development and acquisition of
new product lines and services, the impact of competitive products
or pricing from technological changes, the effect of economic
conditions and other uncertainties. The forward-looking statements
contained herein involve risks and uncertainties that could cause
actual results to differ materially from the expectations contained
in any such forward-looking statements. These risks include, but
are not limited to: failure to manage operating expenses or
integrate new companies and/or technologies, each of which could
have a material impact on our business, our financial results, and
the company's stock price. These risks and other factors are
detailed in the Company's regular filings with the U.S. Securities
and Exchange Commission. Most of these factors are difficult to
predict accurately and are generally beyond the Company's control.
Forward-looking statements speak only as to the date they are made
and ONE Bio, Corp. does not undertake to update forward-looking
statements to reflect circumstances or events that occur after the
date the forward-looking statements are made.
Company Contact: Jeanne Chan Senior VP Tel. +888.676.4445
jchan@onehcorp.com Contact: Investor Relations & Corporate
Communications 888-676-4445 ir@onehcorp.com
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jun 2024 to Jul 2024
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jul 2023 to Jul 2024